Nice Chart, page-3

I have finished accumulating by BXN position, I just can't buy anymore.

So here is the basic tenement of my research for you all. Do your own research please, judging by how little I make mine isn't that good!!

I own BXN because I believe Mr Chua will do the same as he did at NEW IMAGE before (Kiwi company, was listed). That's why he's kind of taken over BXN.

Mr Chua drove all the revenue at NEW Image before the MD decided they didn't want to sell BK18 in multi level marketing schemes but instead try and be the next A2. ruined the company, Mr Chua decided to leave.

Look at the share price of NEW  (New Image) on the NZX from 2008 to 2011. 10c to 83c in one year. Stock fell after Mr Chua left the business. MR Chua (now MD and major owner of BXN) and the NEW MD took the business private.

Mr Chua drove sales in Malaysia alone up to $56m up 578% in one year alone.

Multi level marketing schemes are usually around 15% net profit.

So BXN could be doing $5m NPAT in less than two years.  Stock has over $4m of cash in the market cap.

Below is some chat from the NZ equivalent of Hotcopper, as NEW's share price rose astronomically.

If you're thinking about buying BXN, do some work on the new MD and NEW image. Then I think you will buy more.

This stock should go through 15c by this time next year



Hotcopper type chat on NEW’s rampage up in 2009
http://www.sharetrader.co.nz/archive/index.php/t-1577.html



***********
September 2009, Mr Chua sells his share sin NEW
9 Sept09 Senior Manager NH Chua sells 2m @65c to them
From the Top 20 list - NZ Central Securities Depository have suddenly appeared into Top #4 holder with 13.5m shares.

Where did they get the shares from ?

7 May09 New Image issues 5m @36c to “one major New Zealand institutional investor”

Insto wants more but so little on offer it goes to existing large holders.

May-Aug Top #5 Holder E J B Ltd lightens from 15 to 13m by feeding NZCSD 2m shares

I had commented on other thread that NEW won’t be a total match for investment criteria but they are VERY keen to get on board particularly after the 27 Aug09 Company announces their great result. Then..

8 Sept09 Director R Thompson sells 2m @65c to them

9 Sept09 Senior Manager NH Chua sells 2m @65c to them

Total 11m, sorry can’t figure where rest came from.

************
22-Oct 2009, chatter about  a maylasian spin off

Chief Executive Stephen Lyttelton says from 1 January 2010, the NZX-listed
company will receive a tariff reduction on its colostrum products exported to
Malaysia from 5% to zero. The company's lead export product to Malaysia is
its powdered daily breakfast drink, Alpha Lipid Lifeline, containing
colostrum, probiotics, vitamins and calcium.

"With Malaysia accounting for more than half of our total revenues of just
under $100 million in the year to June 2009, you can see that the tariff
reductions there will have a beneficial impact on the
group's bottom line,"
Mr Lyttelton says.

New Image's accounts show revenues from Malaysia for the June year at $56.3
million, up 578% on the previous year. The demand for New Image's health and
wellness products in Malaysia saw the company establish a new 850sq m
regional head office in Kuala Lumpur in July this year. The company is also
investigating the feasibility of floating the Malaysia arm of New Image on
the Malaysian stock exchange, to give the opportunity for the company's
distributors to invest directly in the business there.

*********
4-11-2009
RESPONSE OF NEW IMAGE TO SHARE PRICE ENQUIRY

New Image Group Limited confirms that there is no material information that
has not been disclosed to the market that would account for the drop in the
company's share price.

It has no reason to revise the positive outlook provided at the company's
annual general meeting on 22 October on the back of a 22% growth in revenue
for the first quarter to 30 September compared to the same period for the
previous year.

New Image Group Limited believes the fall in its share price in the past week
can be attributed to two reasons:

First, the off-market sale of two parcels of its shares, including one by a
former director, to a major institutional investor at a discount to the
market price. The company has no control over such transactions. A series
of sales of such substantial shareholdings by any director are not viewed
favourably by the company's board. Dr Thomson has his own reasons for
selling, which the company is not privy to but does not believe to be related
to the current trading position of the company.

Secondly, there has been some speculation about the company in the Sunday
Star Times and in particular an article that appeared in that newspaper last
Sunday. This article may have unnecessarily unsettled some investors. The
article highlighted the sale of a substantial number of shares in the company
by Dr Ray Thomson, whose resignation as a director was announced at the
company's annual general meeting on 22 October. This was the second media
report in that newspaper concerning Dr Thomson's New Image share
transactions. In the opinion of the company, the issues raised in the
article hardly justified the overall conclusion and the article's headline.
These issues were unrelated to the company's current business and prospects